
Bavarian Nordic begins mpox vaccine trial in pregnant women and infants
Bavarian Nordic has initiated two Phase III clinical trials of its mpox vaccine, Jynneos, in pregnant and breastfeeding women, as well as infants aged under two years. The first infants have been dosed in one Phase III study (NCT06844487), which aims to …